Korean J Pediatr.  2005 Apr;48(4):443-447.

A Case of Systemic Castleman's Disease in a Child and Successful Treatment with Oral Prednisolone

Affiliations
  • 1Department of Pediatrics, University of Ulsan College of Medicine, Seoul, Korea.
  • 2Department of Pathology, University of Ulsan College of Medicine, Seoul, Korea.
  • 3Department of Pediatrics, College of Medicine, Dankook University, Cheonan, Korea. lmjped@yahoo.co.kr
  • 4Department of Pediatrics, College of Medicine, Konkuk University, Chungju, Korea.

Abstract

Castleman's disease is a rare non-neoplastic lymphoproliferative disorder of unknown etiology. It is divided into three histologic subtypes; hyaline-vascular(HV), plasma cell(PC) type and mixed type (HV-PC). It has two clinical expressions. The localized form, which presents as a slow growing mass, has a relatively benign clinical course. The multicentric form is multilocated and holds significant morbidity. The mainstay of treatment of the localized form is surgical resection. The multicentric form requires medical treatment comprising prednisolone and other immunosuppressor drugs. The disease in children seems to have a more favorable course than in adults. We report a 13-year- old boy with Castleman's disease of multicentric form who was successfully treated with prednisolone and intravenous immunoglobulin.

Keyword

Castleman's disease; Child; Prednisolone; Immunoglobulin

MeSH Terms

Adult
Child*
Giant Lymph Node Hyperplasia*
Humans
Immunoglobulins
Lymphoproliferative Disorders
Male
Plasma
Prednisolone*
Immunoglobulins
Prednisolone
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr